Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

RHÖN-KLINIKUM Aktiengesellschaft (RHK.F)

Compare
14.80
+0.40
+(2.78%)
As of 8:03:02 AM GMT+2. Market Open.
Loading Chart for RHK.F
  • Previous Close 14.40
  • Open 14.80
  • Bid 14.90 x 100000
  • Ask 15.40 x 100000
  • Day's Range 14.80 - 14.80
  • 52 Week Range 10.50 - 15.70
  • Volume 107
  • Avg. Volume 36
  • Market Cap (intraday) 997.569M
  • Beta (5Y Monthly) -0.03
  • PE Ratio (TTM) 22.77
  • EPS (TTM) 0.65
  • Earnings Date May 8, 2025
  • Forward Dividend & Yield 0.10 (0.69%)
  • Ex-Dividend Date Jun 4, 2025
  • 1y Target Est 16.00

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. It also operates acute hospitals, medical care centers, and rehabilitation hospitals. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.

www.rhoen-klinikum-ag.com

14,067

Full Time Employees

December 31

Fiscal Year Ends

Recent News: RHK.F

View More

Performance Overview: RHK.F

Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

RHK.F
7.25%
DAX P (^GDAXI)
6.47%

1-Year Return

RHK.F
33.33%
DAX P (^GDAXI)
19.31%

3-Year Return

RHK.F
5.65%
DAX P (^GDAXI)
49.66%

5-Year Return

RHK.F
15.49%
DAX P (^GDAXI)
105.77%

Compare To: RHK.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RHK.F

View More

Valuation Measures

Annual
As of 4/15/2025
  • Market Cap

    970.61M

  • Enterprise Value

    693.54M

  • Trailing P/E

    22.15

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.60

  • Price/Book (mrq)

    0.74

  • Enterprise Value/Revenue

    0.43

  • Enterprise Value/EBITDA

    5.67

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.32%

  • Return on Assets (ttm)

    1.62%

  • Return on Equity (ttm)

    3.47%

  • Revenue (ttm)

    1.87B

  • Net Income Avi to Common (ttm)

    43.35M

  • Diluted EPS (ttm)

    0.65

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    409.46M

  • Total Debt/Equity (mrq)

    11.29%

  • Levered Free Cash Flow (ttm)

    9.66M

Research Analysis: RHK.F

View More

Company Insights: RHK.F

Research Reports: RHK.F

View More

People Also Watch